An attempt to stretch the benefit: Re-challenge with PARP inhibitors in ovarian cancer. Gonzalez-Ochoa E, Oza AM. Clin Cancer Res 2023 May 16:CCR-23-0652. doi: 10.1158/1078-0432.CCR-23-0652.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gonzalez-Ochoa E, Oza AM. An attempt to stretch the benefit: Re-challenge with PARP inhibitors in ovarian cancer. Clin Cancer Res 2023 May 16:CCR-23-0652. doi: 10.1158/1078-0432.CCR-23-0652.
PMID: 37191665